Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Wilcox

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Kidney International. Supplement|November 1, 1990
Angiotensin II and thromboxane in the regulation of blood pressure and renal functionC S Wilcox, W J Welch
Seminars in Nephrology|October 7, 2000
Ischemic nephropathy/azotemic renovascular diseaseS C Textor, C S Wilcox
Experimental Biology and Medicine (Maywood, N.J.)|July 11, 2001
Oxidative stress: cause or consequence of hypertensionC S Wilcox, W J Welch
The Journal of Clinical Psychiatry|February 1, 1992
Paroxetine in major depression: a double-blind trial with imipramine and placeboJ B Cohn, C S Wilcox
Kidney International. Supplement|September 15, 1998
Macula densa nitric oxide synthase: expression, regulation, and functionC S Wilcox, W J Welch
British Medical Journal|October 9, 1971
Assessment of autonomic function in patients with a Parkinsonian syndromeM J Aminoff, C S Wilcox
Kidney International|April 25, 2001
The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetesC G Schnackenberg, C S Wilcox
Journal of the American Society of Nephrology : JASN|January 1, 1992
Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymphC S Wilcox, V J Dzau
Kidney International. Supplement|June 1, 1996
TGF and nitric oxide: effects of salt intake and salt-sensitive hypertensionC S Wilcox, W J Welch
British Journal of Clinical Pharmacology|April 1, 1976
Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndromeC S Wilcox, M J Aminoff
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Kidney International. Supplement|November 1, 1990
Angiotensin II and thromboxane in the regulation of blood pressure and renal functionC S Wilcox, W J Welch
Seminars in Nephrology|October 7, 2000
Ischemic nephropathy/azotemic renovascular diseaseS C Textor, C S Wilcox
Experimental Biology and Medicine (Maywood, N.J.)|July 11, 2001
Oxidative stress: cause or consequence of hypertensionC S Wilcox, W J Welch
The Journal of Clinical Psychiatry|February 1, 1992
Paroxetine in major depression: a double-blind trial with imipramine and placeboJ B Cohn, C S Wilcox
Kidney International. Supplement|September 15, 1998
Macula densa nitric oxide synthase: expression, regulation, and functionC S Wilcox, W J Welch
British Medical Journal|October 9, 1971
Assessment of autonomic function in patients with a Parkinsonian syndromeM J Aminoff, C S Wilcox
Kidney International|April 25, 2001
The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetesC G Schnackenberg, C S Wilcox
Journal of the American Society of Nephrology : JASN|January 1, 1992
Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymphC S Wilcox, V J Dzau
Kidney International. Supplement|June 1, 1996
TGF and nitric oxide: effects of salt intake and salt-sensitive hypertensionC S Wilcox, W J Welch
British Journal of Clinical Pharmacology|April 1, 1976
Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndromeC S Wilcox, M J Aminoff
Pageof 19